miR-29a-3p-dependent COL3A1 and COL5A1 expression reduction assists sulforaphane to inhibit gastric cancer progression

Biochem Pharmacol. 2021 Jun:188:114539. doi: 10.1016/j.bcp.2021.114539. Epub 2021 Apr 2.

Abstract

The antitumor properties of cruciferous vegetables are mainly due to their high content of isothiocyanates, and sulforaphane (SFA) is the most well-known compound. The aim of this study was to determine the mechanism of SFA inhibiting gastric cancer (GC) progression. After verifying SFA suppressing GC growth in vivo, we utilized the GSE79973 and GSE118916 datasets to identify the GC development signatures that overlap with the RNA-seq analysis in SFA-treated AGS cells. GSEA of the RNA-seq data indicated that SFA regulation of GC progression was related to extracellular matrix and collagens; thus, we identified COL3A1 and COL5A1 as the targets of SFA, which functioned as oncogenes. We found positive correlations between COL3A1 and COL5A1 expression in GC cells, and confirmed that miR-29a-3p is the common regulator of their expression. RNA immunoprecipitation assays based on Ago2, Dicer, and exportin-5 showed that SFA could promote mature miR-29a-3p generation. We also proved that SFA inactivated the Wnt/β-catenin pathway in GC cells in a miR-29a-3p-dependent manner. Overall, SFA boosts miR-29a-3p maturation to downregulate COL3A1 and COL5A1 and inactivate the Wnt/ β -catenin pathway to suppress GC progression.

Keywords: COL3A1; COL5A1; Sulforaphane; The Wnt/ β -catenin pathway; miR-29a-3p.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticarcinogenic Agents / pharmacology
  • Anticarcinogenic Agents / therapeutic use*
  • Cell Line, Tumor
  • Collagen Type III / antagonists & inhibitors
  • Collagen Type III / biosynthesis*
  • Collagen Type III / genetics
  • Collagen Type V / antagonists & inhibitors
  • Collagen Type V / biosynthesis*
  • Collagen Type V / genetics
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Isothiocyanates / pharmacology
  • Isothiocyanates / therapeutic use*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • MicroRNAs / biosynthesis*
  • MicroRNAs / genetics
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / metabolism*
  • Sulfoxides / pharmacology
  • Sulfoxides / therapeutic use*
  • Xenograft Model Antitumor Assays / methods

Substances

  • Anticarcinogenic Agents
  • COL3A1 protein, human
  • COL5A1 protein, human
  • Collagen Type III
  • Collagen Type V
  • Isothiocyanates
  • MIRN29a microRNA, human
  • MicroRNAs
  • Sulfoxides
  • sulforaphane